Back to search
FDAFDA · Food and drugs·Recall number Z-0104-2021

Albumin Gen.2, Catalog 05166861190

Published October 21, 2020 · Recall initiated: August 27, 2020

Summary

FDA records medical device Class III recall Z-0104-2021, published October 21, 2020 and initiated August 27, 2020. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 11963; Lot: lots 43031001, 43718901. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diagnostics Operations, Inc.
Distributor
Domestic distribution nationwide.
Lot
lots 43031001, 43718901
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Albumin Gen.2, Catalog 05166861190 recalled?

Yes. FDA published recall Z-0104-2021 on October 21, 2020. Reported hazard: Roche has confirmed customer complaints of low quality (QC) recovery and invalid calibrations for the identified products. A discoloration (yellow color) was observed and is the result of cross contamination between the R1 and R3 reagents.

What should I do if I have this product?

Voluntary: Firm initiated